Top Trends Transforming the Plantar Fasciitis Treatment Market Landscape in 2025: Technological Advancements In Plantar Fasciitis Treatment Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Plantar Fasciitis Treatment Industry Market Size Be by 2025?
In the past few years, the market size for treatments of plantar fasciitis has experienced substantial growth, set to increase from $1.68 billion in 2024 to $2.08 billion in 2025 with a CAGR of 24.0%. This incredible expansion during the historical period can be associated with factors such as alternative treatment methods, increased patient understanding and awareness, techniques for managing pain, escalating instances of sports-related injuries and advancements in physical therapy techniques.

What's the Long-Term Growth Forecast for the Plantar Fasciitis Treatment Market Size Through 2029?
The market size of treatment for plantar fasciitis is projected to experience significant expansion in the forthcoming years. By 2029, it is anticipated to reach a value of $4.73 billion, with a compound annual growth rate (CAGR) of 22.8%. The expected growth during this time frame is due to a multitude of factors including shifts in regulations and approvals, the introduction of patient-oriented strategies, ongoing research and clinical studies, and an intensified focus on personalized medicine coupled with the increasing age demographics. Notable trends anticipated in this period entail targeted rehabilitation methodologies, advancements in orthopedic devices, studies in biomechanics, progress in alternative therapies, and an emphasis on patient instruction and self-care.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Plantar Fasciitis Treatment Market Expansion?
The plantar fasciitis market is anticipated to experience accelerated growth due to an increase in obesity rates. Obesity, a health concern characterized by an abnormal or excessive amount of fat accumulation, is a considerable risk factor. Being overweight corresponds to a body mass index (BMI) of 25 or higher, while obesity is identified with a BMI greater than 30. An individual with a normal weight has almost six times less likelihood to develop plantar fasciitis compared to an individual with a BMI of 30 or beyond. As an example, the Centers for Disease Control and Prevention (CDC), a governmental organization in the US, produced data in 2022 showing that there are now 22 states with an adult obesity prevalence of 35% or more, an increase from 19 states in 2021. Consequently, the escalating obesity rates are contributing to the expansion of the plantar fasciitis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp

What Are the Key Trends Driving Plantar Fasciitis Treatment Market Growth?
The proliferation of cutting-edge technologies is a significant trend emerging in the plantar fasciitis treatment market. Top-tier companies in the market for plantar fasciitis treatment are bringing in and deploying groundbreaking technologies to overhaul treatment for plantar heel pain, while expanding their geographical footprint to maintain their market stance. For example, ZetrOZ Systems, an ultrasound technology production company based in the US, launched the Sam X1 in December 2022. This is the sole wireless ultrasound gadget with FDA accreditation for home use. The Sam X1 wireless device can act as a treatment option for soft tissue damage and plantar fasciitis, promoting cell proliferation without the requirement for drugs or surgery. It has demonstrated effectiveness in the treatment of a variety of injuries, including plantar fasciitis. The ZetrOZ Sam X1 device enhances blood vessels to transport greater levels of oxygen-rich blood to the healing zone, removing waste products like cytokine enzymes and cells, thereby accelerating the healing trajectory.

How Is the Plantar Fasciitis Treatment Market Segmented?
The plantar fasciitis treatment market covered in this report is segmented -

1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types
2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis
3) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, Topical Treatments
2) By Orthotics: Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, Heel Cups
3) By Shockwave Therapy: Radial Shockwave Therapy, Focused Shockwave Therapy
4) By Surgery: Plantar Fascia Release, Gastrocnemius Recession, Other Surgical Procedures
5) By Other Types: Physical Therapy, Massage Therapy, Stretching And Strengthening Exercises, Alternative Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9385&type=smp

Which Companies Are Leading the Charge in Plantar Fasciitis Treatment Market Innovation?
Major companies operating in the plantar fasciitis treatment market include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl's Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc.

Which Regions Are Leading the Global Plantar Fasciitis Treatment Market in Revenue?
North America was the largest region in the plantar fasciitis treatment market in 2024. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9385

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.